These findings demonstrate how hyperglycemia, through a complex protein cascade, induced HIPK2 downregulation and consequently impaired p53 apoptotic activity, revealing a novel link between diabetes/obesity and tumor resistance to therapies. Here, HIPK2 is linked to obesity due to melanocortin 4 receptor deficiency.